The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis

Catecholamine theories of reward: A critical review

1978 • 766 citations

Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens

1980 • 736 citations

On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine

1977 • 733 citations

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing

1980 • 717 citations

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

1980 • 696 citations

Treatment of Parkinsonism With Levodopa

1969 • 602 citations

Cortical Dopaminergic Involvement in Cocaine Reinforcement

1983 • 491 citations

Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration

1979 • 460 citations

L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

1969 • 403 citations

Dopaminergic substrates of amphetamine-induced place preference conditioning

1982 • 381 citations

Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats

1976 • 371 citations

Drugs and Reinforcement Mechanisms: A Critical Review of the Catecholamine Theory

1978 • 293 citations

Psychiatric symptoms in Parkinsonism.

1970 • 246 citations

Cocaine-induced place preference conditioning: Lack of effects of neuroleptics and 6-hydroxydopamine lesions

1982 • 241 citations

Psychiatric disturbances in Parkinson's disease.

1972 • 240 citations

Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.

1979 • 211 citations

The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex.

1978 • 211 citations

Depression in Patients with Parkinsonism

1976 • 187 citations

Clinical trials with amphetamine-blocking drugs.

1972 • 147 citations

Blockade of intravenous amphetamine euphoria in man

1971 • 140 citations

Functional Aspects of the Norepinephrine Receptor Coupled Adenylate Cyclase System in the Limbic Forebrain and its Modification by Drugs which Precipitate or Alleviate Depression: Molecular Approaches to an Understanding of Affective Disorders

1978 • 132 citations

The time course of noradrenergic pre- and postsynaptic activity during chronic desipramine treatment

1980 • 132 citations

Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.

1978 • 130 citations

Depressive symptoms in Parkinson patients referred for thalamotomy.

1967 • 116 citations

Some psychological factors in Parkinsonism

1974 • 100 citations

Psychiatric symptoms during<scp>L</scp>-dopa therapy for Parkinson's disease and their relationship to physical disability

1976 • 88 citations

On the role of ascending catecholaminergic projections in intracranial self-stimulation of the substantia nigra

1977 • 87 citations

Parkinsonism and Depression

1972 • 77 citations

Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome

1977 • 73 citations

Micro topography of Tyrosine Hydroxylase, Glutamic Acid Decarboxylase, and Choline Acetyltransferase in the Substantia Nigra and Ventral Tegmental Area of Control and Parkinsonian Brains

1981 • 68 citations